Abstract
We report the case of an 88-year-old man with coronavirus disease 2019 (COVID-19) who presented with ARDS and septic shock. The patient had exquisite BP sensitivity to low-dose angiotensin II (Ang-2), allowing for rapid liberation from high-dose vasopressors. We hypothesize that sensitivity to Ang-2 might be related to biological effect of severe acute respiratory syndrome coronavirus 2 infection. The case is suggestive of a potential role for synthetic Ang-2 for patients with COVID-19 and septic shock. Further studies are needed to confirm our observed clinical efficacy.
Original language | English (US) |
---|---|
Pages (from-to) | e55-e58 |
Journal | Chest |
Volume | 158 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2020 |
Keywords
- COVID-19
- SARS-CoV-2
- angiotensin II
- septic shock
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine